Dysosteosclerosis
Description
Dysosteosclerosis is a skeletal dysplasia characterized by progressive osteosclerosis and platyspondyly.
Clinical Features
Top most frequent phenotypes and symptoms related to Dysosteosclerosis
- Intellectual disability
- Seizures
- Global developmental delay
- Short stature
- Hearing impairment
- Hypertelorism
- Nystagmus
- Micrognathia
- High palate
- Macrocephaly
And another 60 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Dysosteosclerosis Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Hearing Loss Panel.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
RPS6KA3, SALL1, SEMA3E, SIX1, SIX5, SLC19A2, SNAI2, SMPX, SOX10, BTD, TCOF1, TECTA, TIMM8A, TJP2, TMPRSS3, USH1C, USH2A, CLRN1, WFS1, ESPN , (...)
View the complete list with 100 more genes
Specificity
1 %
Genes
100 % |
SLC29A3 sequencing.
By Genetic Services Laboratory University of Chicago (United States).
SLC29A3
Specificity
100 %
Genes
100 % |
SLC29A3 deletion/duplication analysis.
By Genetic Services Laboratory University of Chicago (United States).
SLC29A3
Specificity
100 %
Genes
100 % |
SLC29A3.
By Institute for Human Genetics University Clinic Freiburg (Germany).
SLC29A3
Specificity
100 %
Genes
100 % |
SLC29A3. Complete sequencing.
By Instituto de Medicina Genomica Instituto de Medicina Genomica (Spain).
SLC29A3
Specificity
100 %
Genes
100 % |
Histiocytosis-lymphadenopathy plus syndrome (sequence analysis of SLC29A3 gene).
By CGC Genetics (Portugal).
SLC29A3
Specificity
100 %
Genes
100 % |
Histiocytosis-Lymphadenopathy Plus Syndrome via SLC29A3 Gene Sequencing with CNV Detection.
By PreventionGenetics PreventionGenetics (United States).
SLC29A3
Specificity
100 %
Genes
100 % |
Histiocytosis-lymphadenopathy plus syndrome.
By Centogene AG - the Rare Disease Company (Germany).
SLC29A3
Specificity
100 %
Genes
100 % |
You can get up to 16 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
MESH ORPHANET OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHORT-RIB THORACIC DYSPLASIA 11 WITH OR WITHOUT POLYDACTYLY; SRTD11 KENNY-CAFFEY SYNDROME, TYPE 2; KCS2